Cellular Influx, Efflux, and Anabolism of 3-Carboranyl Thymidine Analogs: Potential Boron Delivery Agents for Neutron Capture Therapy
Authors:
- Elena SjuvarssonESElena Sjuvarsson
- Vijaya L. DamarajuVDVijaya L. Damaraju
- Delores MowlesDMDelores Mowles
- Michael B. SawyerMSMichael B. Sawyer
- Rohit TiwariRTRohit Tiwari
- Hitesh K. AgarwalHAHitesh K. Agarwal
- Ahmed KhalilAKAhmed Khalil
- Sherifa HasabelnabySHSherifa Hasabelnaby
- Ayman GoudahAGAyman Goudah
- Robin J. NakkulaRNRobin J. Nakkula
- Rolf F. BarthRBRolf F. Barth
- Carol E. CassCCCarol E. Cass
- 1 November 2013
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 347 (2) , 388-397
Abstract
3-[5-{2-(2,3-Dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH) is a first generation 3-carboranyl thymidine analog (3CTA) that has been intensively studied as a boron-10 (10B) delivery agent for neutron capture therapy (NCT). N5-2OH is an excellent substrate of thymidine kinase 1 and its favorable biodistribution profile in rodents led to successful preclinical NCT of rats bearing intracerebral RG2 glioma. The present study explored cellular influx and efflux mechanisms of N5-2OH, as well as its intracellular anabolism beyond the monophosphate level. N5-2OH entered cultured human CCRF-CEM cells via passive diffusion, whereas the multidrug resistance-associated protein 4 appeared to be a major mediator of N5-2OH monophosphate efflux. N5-2OH was effectively monophosphorylated in cultured murine L929 [thymidine kinase 1 (TK1+)] cells whereas formation of N5-2OH monophosphate was markedly lower in L929 (TK1–) cell variants. Further metabolism to the di- and triphosphate forms was not observed in any of the cell lines. Regardless of monophosphorylation, parental N5-2OH was the major intracellular component in both TK1+ and TK1– cells. Phosphate transfer experiments with enzyme preparations showed that N5-2OH monophosphate, as well as the monophosphate of a second 3-carboranyl thymidine analog [3-[5-(o-carboran-1-yl)pentan-1-yl]thymidine (N5)], were not substrates of thymidine monophosphate kinase. Surprisingly, N5-diphosphate was phosphorylated by nucleoside diphosphate kinase although N5-triphosphate apparently was not a substrate of DNA polymerase. Our results provide valuable information on the cellular metabolism and pharmacokinetic profile of 3-carboranyl thymidine analogs.Keywords
This publication has 34 references indexed in Scilit:
- Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumorsEuropean Journal of Medicinal Chemistry, 2012
- Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: Structural and catalytic propertiesAntiviral Research, 2010
- Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumorsProceedings of the National Academy of Sciences, 2008
- Mechanisms of substrate selectivity forBacillus anthracisthymidylate kinaseProtein Science, 2008
- Uridine Binding and Transportability Determinants of Human Concentrative Nucleoside TransportersMolecular Pharmacology, 2005
- Cell entry and export of nucleoside analoguesVirus Research, 2005
- Cellular Export of Drugs and Signaling Molecules by the ATP-binding Cassette Transporters MRP4 (ABCC4) and MRP5 (ABCC5)Drug Metabolism Reviews, 2005
- Reaction of human UMP‐CMP kinase with natural and analog substratesEuropean Journal of Biochemistry, 2003
- Synthesis of 5-(Carboranylalkylmercapto)-2‘-deoxyuridines and 3-(Carboranylalkyl)thymidines and Their Evaluation as Substrates for Human Thymidine Kinases 1 and 2Journal of Medicinal Chemistry, 1999
- Efficient Incorporation of Anti-HIV Deoxynucleotides by Recombinant Yeast Mitochondrial DNA PolymeraseJournal of Biological Chemistry, 1995